A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients

• Conditions: Respiratory Failure; Pneumonia; COVID-19; Pulmonary Disease; Community-acquired Pneumonia; COPD
• Interventions: Device: RespiraSense

• Registration Number: NCT05384314
• Lead Sponsor: Beaumont Hospital

Brief Summary

A retrospective study to evaluate the predictability of abnormal arterial blood gas measurements through novel observations of continuous trends in electronically measured respiratory in a mixed cohort of respiratory compromised patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-07-12
• Status Verified: 2022-05
• Study First Submitted: 2022-05-17
• Study First Submitted QC: 2022-05-19
• Last Update Submitted: 2022-05-19
• Study First Posted: 2022-05-20
• Last Update Posted: 2022-05-20
• Primary Completion: 2022-10-12
• Study Completion: 2022-12-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 322

Inclusion Criteria

• Respiratory condition is the primary admission diagnosis

Exclusion Criteria

• Pregnant patients in their 2nd or 3rd trimester

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Respiratory Compromised General	RespiraSense	Patients admitted with Pneumonia, COPD, COVID, to be included
COPD	RespiraSense	Patients admitted with COPD as the primary admission.

Primary Outcome Measures

Name	Time	Method
Positive Predictive Value/Precision (PPV)	12 months	Positive Predictive Value/Precision (PPV) of an elevated RespiraSense monitoring Respiratory Rate (RR) for an abnormal ABG - for a single disease state (COPD)

Secondary Outcome Measures

Name	Time	Method
PPV of an elevated RR for an abnormal ABG - for a mix of disease states	12 months	PPV of an elevated RR for an abnormal ABG - for a mix of disease states, all of which fall under Respiratory Failure

Trial Locations

Locations (1)

Beaumont Hospital; 🇮🇪 Dublin, Ireland